Versor Investments LP Pacira Bio Sciences, Inc. Transaction History

Versor Investments LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$26.32 - $34.31 $115,729 - $150,861	4,397 Added 53.01%	12,692 $428,000
Q3 2023 Nov 06, 2023	SELL	$30.68 - $40.09 $137,262 - $179,362	-4,474 Reduced 35.04%	8,295 $254,000
Q2 2023 Aug 07, 2023	SELL	$36.12 - $47.5 $38,829 - $51,062	-1,075 Reduced 7.77%	12,769 $511,000
Q1 2023 May 05, 2023	SELL	$35.53 - $43.38 $78,272 - $95,566	-2,203 Reduced 13.73%	13,844 $564,000
Q4 2022 Jan 30, 2023	BUY	$38.19 - $57.45 $612,834 - $921,900	16,047 New	16,047 $619,000
Q2 2022 Jul 27, 2022	BUY	$51.49 - $81.64 $216,258 - $342,888	4,200 New	4,200 $245,000
Q2 2020 Jul 30, 2020	SELL	$30.8 - $52.47 $453,745 - $772,988	-14,732 Closed	0 $0
Q1 2020 Apr 28, 2020	BUY	$28.4 - $50.7 $418,388 - $746,912	14,732 New	14,732 $494,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

Stay updated on Versor Investments LP with notifications on news.